SAB Biotherapeutics Stock Analysis - Daily Balance Of Power

Key Indicators . Daily Balance Of Power . Stocks . USA . 
Stock . SAB Biotherapeutics
SABS Stock  USD 3.72  -0.39  -9.49%   
Balance of Power measures where the close finished relative to the open, showing whether buyers or sellers controlled the session.

Daily Balance Of Power Analysis Today

Balance of Power measures where the close finished relative to the open, showing whether buyers or sellers controlled the session. The current Daily Balance Of Power for SAB Biotherapeutics is -0.65. This reading indicates elevated price movement across the session.
  Previous Daily Balance Of PowerDaily Balance Of PowerTrend
-0.09-0.65
VolatilityBacktestInformation Ratio  

SAB Biotherapeutics Trading Date Momentum

On May 11 2026 SAB Biotherapeutics was traded for 3.72 at the closing time. The top price for the day was 4.27 and the lowest listed price was 3.67 . The trading volume for the day was 2.6 M. The trading history from May 11, 2026 remained within defined bounds. The trading price change against the current closing price is 12.90% .
BOP trending toward the high of its range signals sustained buying pressure on SAB Biotherapeutics. A decline from positive toward zero suggests weakening demand. Conversely, BOP moving from deeply negative toward zero indicates diminishing selling pressure. Divergence between BOP direction and price direction may signal a pending reversal.
Compare SAB Biotherapeutics to competition

Related Price-Series Methods for SAB Biotherapeutics

These methods summarize the same price history through smoothing, range, and momentum calculations. Reviewing them alongside Daily Balance Of Power helps compare stable sessions with periods of wider price movement in SAB Biotherapeutics.
Naive Prediction
Simple Exponential Smoothing
Double Exponential Smoothing
Triple Exponential Smoothing
Simple Regression
Polynomial Regression
Simple Moving Average
4 Period Moving Average
8 Period Moving Average
20 Period Moving Average

SAB Biotherapeutics Related Equities

These related stocks within the Health Care space give benchmarks for judging SAB Biotherapeutics' results, margins, and growth trend. Growth rate gaps between SAB Biotherapeutics and its peers often explain pricing differences in the market. A stock that beats its peers on many metrics often deserves a closer look from value-focused investors. The data below allows side-by-side review across the most common financial metrics.
 Risk & Return  Correlation

SAB Biotherapeutics Market Strength Events

Accumulation/Distribution and Balance of Power for SAB Biotherapeutics reveal whether buying or selling pressure dominates recent sessions. Balance of Power trending positive indicates that buyers are consistently closing SAB Biotherapeutics near session highs. These signals help explain whether price direction and session structure are moving together for SAB Biotherapeutics.
Accumulation Distribution368272.0
Daily Balance Of Power-0.65
Rate Of Daily Change0.91
Day Median Price3.97
Day Typical Price3.89
Price Action Indicator-0.44
Period Momentum Indicator-0.39
Relative Strength Index47.86

SAB Biotherapeutics Risk Indicators

Risk indicator analysis for SAB Biotherapeutics quantifies how much price variability the stock has exhibited over the measurement window. Downside variance exceeding total variance indicates that negative moves in SAB Biotherapeutics have been larger or more frequent than positive ones. Mean deviation provides a more intuitive measure of typical price fluctuation than variance because it stays in the same units as SAB Biotherapeutics' price.
Mean Deviation3.12
Standard Deviation4.23
Variance17.92
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

SAB Biotherapeutics Short Properties

Short-interest data for SAB Biotherapeutics reveals whether bearish conviction in the market is gaining traction. This is applicable when the question is whether bearish pressure is starting to shape the market's reaction function.
Common Stock Shares Outstanding61.34 million
Cash And Short Term Investments96.59 million

Additional Tools for SAB Stock Analysis

Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.